3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
11
Terminated
5
Withdrawn
1
Unknown
1
Recruiting
1
No longer available
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
14
Other solid neoplasm
14
Sarcoma
1
Other neoplasm
1
Myeloid
1
Gastrointestinal
1
Conditions
Sarcoma
60
Gliosarcoma
19
Glioblastoma
19
Osteosarcoma
15
Lymphoma
14
Central Nervous System Neoplasms
13
Dendritic Cell Sarcoma, Interdigitating
11
Rhabdomyosarcoma
10
Oligodendroglioma
10
Neuroblastoma
10
Neoplasms
10
Lymphoma, Large B-Cell, Diffuse
10
Brain Neoplasms
10
Bone Neoplasms
10
Astrocytoma
10
Recurrence
9
Breast Neoplasms
9
Sarcoma, Ewing
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, Non-Hodgkin
8
Liposarcoma
8
Glioma
8
Burkitt Lymphoma
8
Wilms Tumor
7
Neoplasm Metastasis
7
Melanoma
7
Hodgkin Disease
7
Gastrointestinal Stromal Tumors
7
Ovarian Neoplasms
6
Medulloblastoma
6
Interventions
tislelizumab
1
regorafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Mesothelioma, Malignant
×
Sarcoma
×
Clear all
NCT05582031
2023-06-07
REFIT-MSS
Translational Research in Oncology
Phase 2
Withdrawn